
About this episode
Steven Freidkin, CEO and Founder of Ntiva, Inc. and Christopher Vollmond-Carstens, Chief M&A Officer at Ntiva, Inc.
In a highly fragmented industry, roll-ups are a great growth strategy. But integrating multiple entities can be difficult, especially if you don't have a proven framework. Ntiva has been successful in its M&A strategy and has completed 15 acquisitions as of today.
In this episode of the M&A Science Podcast, Steven Freidkin, CEO and Founder of Ntiva, Inc. and Christopher Vollmond-Carstens, Chief M&A Officer at Ntiva, Inc., share their strategy on how to execute the roll-up strategy in the tech industry.
Things you will learn:
• Creating value using a roll-up strategy
• Evaluating a target company
• Importance of recurring revenue
• Red flags pre-LOI
• Biggest advice for first-timers
This episode is sponsored by the DealRoom.
Ready to take your M&A to the next level with software made to manage each stage of the deal process? See how DealRoom can facilitate your next deal at https://dealroom.net
******************
Episode Bookmarks
00:00 Intro
08:04 Creating value using roll-up strategy
12:38 Pitching to private equity
18:32 Evaluating a target company
22:30 Importance of recurring revenue
23:35 Customer Concentration
26:42 Challenges of doing roll-ups
30:36 Mismanaging M&A
37:52 Deal Sourcing
43:46 Red flags pre-LOI
46:53 Deal structure on roll-ups
51:52 Biggest advice for first-timers
52:46 Craziest thing in M&A
Get every episode summarized
Each time M&A Science publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from M&A Science

Cultural Fit Over EBITDA: How Salas O'Brien Built a 30-Merger Program Without a...
M&A Science

Cross-Border M&A: How to Do Deals in Italy with Mauro Sambati and Donato Romano
M&A Science

Four Questions That Defined a $1 Billion Deal with Robert Lovegrove
M&A Science

Stop Falling in Love with the Deal: Guardrails for High-Volume Acquisitions with...
M&A Science